Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_assertion type Assertion NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_head.
- NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_assertion description "[In breast cancer patients, no significant association was observed between the ACE genotypes and poor prognostic factors, such as negative hormone receptor status, histological grade, lymph node involvement, higher number of lymph node metastases, and c-erb B2 overexpression, except that tumor size greater than 2 cm is associated with DD genotype (p = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_provenance.
- NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_assertion evidence source_evidence_literature NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_provenance.
- NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_assertion SIO_000772 17023764 NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_provenance.
- NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_assertion wasDerivedFrom befree-20150227 NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_provenance.
- NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_assertion wasGeneratedBy ECO_0000203 NP350141.RAQzF06K2qBzG0sJujvxPfFh9HRVE8YEEMaGXDEeigo-0130_provenance.